Charting a New Course in Cancer Immunotherapy

Immune-Onc is translating unique scientific insights to develop the next wave of biotherapeutics for cancer.

Screen Shot 2018-08-21 at 8.11.39 AM.png

Turning the Tide on Immune Suppression

Cancer remains a formidable and elusive foe, claiming the lives of too many people around the world. Immunotherapy, which harnesses the body’s own immune system to fight against disease, has changed the way cancer is treated, including the potential to cure. Recent breakthroughs in our understanding of the tumor microenvironment and the immune suppressive pathways may yield entirely new biologic therapies that can further unlock the immune system’s ability to defeat cancer.


Science at Our Core, Patients in Our Hearts

We aspire to re-write the current roadmap for people with cancers that offer little hope of survival. Through the application of groundbreaking scientific discoveries and with tireless dedication, we aim to transform patient lives through pioneering biologic treatments.


Collaborators & Investors

The team at Immune-Onc Therapeutics have significant industry experience in bringing innovative biologic treatments to patients with serious diseases. Combining our deep expertise in drug development with strategic research collaborations with leading academic institutions, we aim to discover and develop new immunomodulatory approaches to cancer treatment. Our efforts are backed by seasoned investors committed to making our vision a reality for patients.